Do Pharmacies Give Allergy Shots? Why CVS and Walgreens Can't Do Immunotherapy

Three structural barriers prevent retail pharmacies from offering allergen immunotherapy. First, allergy shot extracts are custom-formulated per patient based on individual allergen testing results — they cannot be stocked as standard pharmacy inventory. Second, the 0.1-0.2% systemic reaction rate per injection requires immediate emergency response capabilities including epinephrine, oxygen, IV access, resuscitation equipment, and an on-site physician — resources that exceed the setup of even the most comprehensive retail pharmacy immunization program. Third, pharmacist scope of practice does not include supervision of allergen immunotherapy programs in any US state. These barriers are structural, not regulatory technicalities — even if laws were changed, the first two barriers would require pharmacies to fundamentally transform into clinical medical facilities.

Some pharmacies with in-store clinics (such as CVS MinuteClinic) offer corticosteroid injections (Kenalog/triamcinolone) and intramuscular diphenhydramine for acute allergy symptoms. These are not allergen immunotherapy — they are symptom-management treatments. A Kenalog injection suppresses your allergic immune response broadly for 2-6 weeks. It does not contain allergens, does not create immune tolerance, and does not modify the underlying allergic disease mechanism. Patients sometimes mistake these treatments for allergy shots (immunotherapy) because both involve a needle and are called allergy shots colloquially. Understanding the distinction is important for setting realistic treatment expectations.

Compounding pharmacies do prepare allergen extracts — this is actually a legitimate and important role in the immunotherapy supply chain. When an allergist prescribes a patient-specific allergen extract, the formula may be compounded at the allergist's in-house facility or sent to a specialized compounding pharmacy that handles allergen extract preparation. However, the compounding role (preparing the extract to the allergist's specification) is entirely distinct from the administration role (injecting the extract into the patient). The compounding pharmacy prepares and ships the extract to the allergist's clinic, where it is then administered by trained clinical personnel under physician supervision. Compounding pharmacies do not administer immunotherapy injections in their retail locations.

For allergen immunotherapy (allergy shots), you need a board-certified allergist or an ENT physician with allergy training to prescribe and oversee treatment — a retail pharmacy cannot. Find a board-certified allergist using the AAAAI finder at allergist.aaaai.org or the ACAAI locator at acaai.org/locate-an-allergist. Confirming your allergen sensitivities through testing — at the allergist's office or via a prior blood IgE test — lets the consultation focus on treatment planning. If clinic visits are a barrier, you do not have to give up on the shots themselves: for eligible maintenance patients, at-home SCIT through Curex delivers allergist-prescribed allergy shots at home, with the first injection and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand. Sublingual immunotherapy drops (SLIT) remain a separate needle-free modality to discuss with your allergist.

Retail pharmacies provide meaningful allergy care within their appropriate scope. They dispense over-the-counter antihistamines (cetirizine, loratadine, fexofenadine, diphenhydramine) and fill prescription nasal corticosteroids (fluticasone, budesonide, mometasone). Pharmacists can counsel patients on comparing antihistamines and nasal sprays for symptom management. Some pharmacies with in-store clinics (MinuteClinic, Redi-Clinic, Health Hub) can diagnose and treat mild-to-moderate allergic rhinitis, prescribe medications, and in some cases administer corticosteroid injections for acute allergy flares. What retail pharmacies cannot provide is the disease-modifying treatment that allergen immunotherapy offers — the only treatment with evidence for lasting reduction in allergic sensitivity after stopping treatment.

There is growing academic discussion about expanding pharmacist roles in sublingual immunotherapy (SLIT drops) as a future access model, since drops can be dispensed rather than injected — several European countries have pharmacy-based SLIT dispensing. However, pharmacist-administered SCIT injections in the US face the same three structural barriers in any scenario: custom extract requirements, emergency-infrastructure needs, and physician-supervision requirements. The access model already emerging is telehealth-supervised at-home immunotherapy — a remote board-certified physician reviews IgE testing, prescribes a personalized serum sterile-compounded to USP <797> standards, confirms a prescribed epinephrine auto-injector is on hand, and supervises self-administered doses live over Zoom (as Curex does for at-home SCIT) — rather than retail-pharmacy SCIT injection programs.